In-licensing
- In-licensing
- View
Dermatology: Skin Cancer, Anti-fungals, Dermoceuticals & more
New Dermatology products in early to late phases or already marketed required for acquisition or in-licensing for Mexico
Full description
Looking for any compound/technology in Dermatology, including Skin Cancer, Anti-fungals, Dermoceuticals etc. (oral&topical) to complete and strengthen our current product line. Patents preferred.
Development status
Early Stage
Type of business relationship sought
DARIER is very open and flexible about the type of deal, ranging from licensing to acquisition, favoring fair, long-term and profit/risk sharing opportunities.
Related reports
Market Research Reports provided by reports.innovaro.com
Jul 2011 - 96 pages - $3,835
Feb 2011 - 20 pages - $350
Feb 2011 - 20 pages - $350
Feb 2011 - 23 pages - $350
Feb 2011 - 20 pages - $350
Feb 2011 - 20 pages - $350
Feb 2011 - 20 pages - $350
Feb 2011 - 20 pages - $350
Feb 2011 - 27 pages - $350
Feb 2011 - 95 pages - $3,835
Licensing contact
Company details
Laboratorios Dermatologicos Darier, S.A. de C.V
Darier Laboratories is a vertically integrated specialty pharmaceutical company that develops, manufactures, markets, and sells therapies and technologies exclusively in dermatology.
View profileRelated technologies
Related categories
- Industry sector
- Biotechnology
- Medical device
- Non-profit org./Government
- Drug delivery / Oral liquid
- Drug delivery / Oral solid
- Pharmaceutical
- Drug delivery / Systemic
- Drug delivery / Topical
- Therapeutic target
- Dermatological / Burns
- Dermatological / Cosmetic procedures
- Dermatological
- Dermatological / Fungal infection
- Oncology / Skin cancer / Melanoma
- Oncology / Skin cancer
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us